Post-Market Bioequivalence of Generic Drug Product
Inactive
Contract Opportunity
Notice ID
75F40124R00023
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
FOOD AND DRUG ADMINISTRATION
Office
FDA CENTER FOR DRUG EVALUATION AND RESEARCH
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Solicitation (Updated)
- Updated Published Date: Jan 03, 2024 11:50 am EST
- Original Published Date: Dec 05, 2023 04:43 pm EST
- Updated Date Offers Due: Jan 24, 2024 10:00 am EST
- Original Date Offers Due: Jan 12, 2024 10:00 am EST
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: Feb 08, 2024
- Original Inactive Date: Jan 27, 2024
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
- NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of Performance:
Description
Post-Market Bioequivalence of Generic Drug Product
01/03/2024- Amendment to provide the government's response to quesions and to provide a new proposal due date.
Proposals are due 10AM EST 01/24/2024
Attachments/Links
Contact Information
Contracting Office Address
- 10903 New Hampshire Avenue
- Silver Spring , MD 20993
- USA
Primary Point of Contact
- Telisha WIlson
- telisha.wilson@fda.hhs.gov
Secondary Point of Contact
History
- Feb 08, 2024 11:55 pm ESTSolicitation (Updated)
- Jan 03, 2024 11:41 am ESTSolicitation (Updated)
- Dec 05, 2023 04:43 pm ESTSolicitation (Original)